View drug registration information details.
Items | Registration information |
ID | 1213 |
No | 1213 |
Brand Name | CIPRODAS-250 |
Ingredients | CIPROFLOXACIN HYDROCHLORIDE USP EQ.TO CIPROFLOXACIN 250 MG/5 ML |
Dosage Form | POWDER FOR SUSPENSION |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 60 ML/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | LOWER RESPIRATORY TRACT INFECTION DUE TO GRAM-NEGATIVE BACTERIA, CHRONIC SUPURATIVE OTITIS MEDIA, ACUTE EXACERBATION OF CHRONIC SINUSITIS, URINARY TRACT INFECTION, GENITAL TRACT INFECTION, INFECTION OF GASTRO-INTESTINAL TRACT, BONE AND JOINTS, SKIN AND SOFT TISSUE, INTR-ABDOMINAL INFECTION, |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE POWDER FORMING A YELLOW COLORED SUSPENSION ON ADDITION OF WATER |
Note | |
License Owner | KONGCHAI-LAO PHARMA SOLE CO.,LTD |
Manufacturer | SALVAVIADAS PHARMACEUTICAL PVT.LTD |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 05 I 5926/25 |
FDD Registration Date | 19-MAY-2025 |
Expiry Date | 18-MAY-2030 |
Back to drug list
|